CD4 and breast carcinoma: In order to validate our findings in ex-vivo tumor tissue samples, we isolated intratumoral and peripheral pDCs from patients with breast cancer, co-cultured them with autologous peripheral CD4+CD45RA+ T cells and measured the fraction of FoxP3+ cells by flow cytometric analysis (Figure 5A).